124 related articles for article (PubMed ID: 23657405)
1. Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the floor of the mouth.
Monteiro-Amado F; Castro-Silva II; Lima CJ; Soares FA; Kowalski LP; Granjeiro JM
Braz Dent J; 2013; 24(1):3-9. PubMed ID: 23657405
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
3. The role of angiogenesis in the spread of oral squamous cell carcinoma.
Penfold CN; Partridge M; Rojas R; Langdon JD
Br J Oral Maxillofac Surg; 1996 Feb; 34(1):37-41. PubMed ID: 8645680
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
[TBL] [Abstract][Full Text] [Related]
5. The matrix metalloproteinase system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
[TBL] [Abstract][Full Text] [Related]
6. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
[TBL] [Abstract][Full Text] [Related]
7. p-Akt and its relationship with clinicopathological features and survival in oral squamous cell carcinoma: an immunohistochemical study.
Pontes HA; Pontes FS; de Jesus AS; Soares MC; Gonçalves FL; de Lucena Botelho T; do Carmo Ribeiro J; Dos Santos Pinto D
J Oral Pathol Med; 2015 Aug; 44(7):532-7. PubMed ID: 25244056
[TBL] [Abstract][Full Text] [Related]
8. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity.
Kusukawa J; Sasaguri Y; Morimatsu M; Kameyama T
J Oral Maxillofac Surg; 1995 May; 53(5):530-4. PubMed ID: 7722722
[TBL] [Abstract][Full Text] [Related]
10. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
11. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Niwa H; Tsuneyama K; Takano Y
Anticancer Res; 2006; 26(5A):3579-83. PubMed ID: 17094486
[TBL] [Abstract][Full Text] [Related]
12. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
Katayama A; Bandoh N; Kishibe K; Takahara M; Ogino T; Nonaka S; Harabuchi Y
Clin Cancer Res; 2004 Jan; 10(2):634-40. PubMed ID: 14760086
[TBL] [Abstract][Full Text] [Related]
13. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Riedel F; Götte K; Schwalb J; Bergler W; Hörmann K
Int J Oncol; 2000 Dec; 17(6):1099-105. PubMed ID: 11078794
[TBL] [Abstract][Full Text] [Related]
14. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma.
Mashhadiabbas F; Mahjour F; Mahjour SB; Fereidooni F; Hosseini FS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):240-50. PubMed ID: 22769410
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
Yorioka CW; Coletta RD; Alves F; Nishimoto IN; Kowalski LP; Graner E
Int J Oncol; 2002 Jan; 20(1):189-94. PubMed ID: 11743663
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Silva RNF; Dallarmi LB; Araujo AKC; Alencar RCG; Mendonça EF; Silva TA; Batista AC; Costa NL
J Oral Pathol Med; 2018 Oct; 47(9):856-863. PubMed ID: 29964301
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential.
Hong SD; Hong SP; Lee JI; Lim CY
Oral Oncol; 2000 Mar; 36(2):207-13. PubMed ID: 10745174
[TBL] [Abstract][Full Text] [Related]
18. An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion.
Simon C; Nemechek AJ; Boyd D; O'Malley BW; Goepfert H; Flaitz CM; Hicks MJ
Laryngoscope; 1998 Nov; 108(11 Pt 1):1686-91. PubMed ID: 9818827
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
[TBL] [Abstract][Full Text] [Related]
20. Development of a New Outcome Prediction Model in Early-stage Squamous Cell Carcinoma of the Oral Cavity Based on Histopathologic Parameters With Multivariate Analysis: The Aditi-Nuzhat Lymph-node Prediction Score (ANLPS) System.
Arora A; Husain N; Bansal A; Neyaz A; Jaiswal R; Jain K; Chaturvedi A; Anand N; Malhotra K; Shukla S
Am J Surg Pathol; 2017 Jul; 41(7):950-960. PubMed ID: 28346327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]